Effect of Jyotishmati capsule in the management of Chittodvega Generalized Anxiety Disorder
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2023/09/057687
- Lead Sponsor
- Reeya Gamne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients willing to take part in research study and ready to give written informed consent.
2.Patients will be selected according to DSM-V, ICD-10 criteria for anxiety disorders.
3.A score of less than 24on HAM-A scale.
4.Age group of 20 to 50 years of either sex.
5.Free of psychiatric conditions other than anxiety.
1.Current primary diagnosis of a comorbid disorder deemed to require treatment prior to GAD, such as major depressive disorder, panic disorder, social phobia, obsessive compulsive disorder, post-traumatic stress disorder, or drug dependency.
2.Currently undertaking CBT with a psychologist condition.
3.GAD (Chittodvega) due to drug abuse, a medication and due to general medical state like Hyperthyroidism
4.Alcoholic, and Self-harm or suicide risk
5.Diagnosed with psychosis, schizophrenia, or bipolar illness currently or in the past
6.Treatment with sertraline for two or more weeks within the previous three months
7.Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method